Related Experiment Videos
Immunohistochemical evaluation of hematologic malignancies
M Miettinen1, R Schwarting, B H Hyun
1Department of Pathology, Jefferson Medical College, Philadelphia, Pennsylvania.
Hematology/Oncology Clinics of North America
|August 1, 1994
Summary
Immunohistochemistry aids in diagnosing hematologic malignancies using advanced monoclonal antibodies. This technique evaluates lymphoma and leukemia by examining proliferation antigens and tumor suppressor genes.
Area of Science:
- Hematopathology
- Oncology
- Immunology
Background:
- Immunohistochemistry is crucial for diagnosing hematologic malignancies.
- Advances in monoclonal antibodies have improved diagnostic capabilities.
- Formaldehyde-fixed, paraffin-embedded tissues are increasingly utilized.
Purpose of the Study:
- To summarize recent developments and current practices in immunohistochemistry for hematologic malignancy diagnosis.
- To discuss the application of monoclonal antibodies in diagnosing small cell lymphoma entities.
- To evaluate the biologic potential of lymphomas and leukemias using specific antibodies.
Main Methods:
- Review of recent literature on immunohistochemistry in hematologic malignancies.
- Discussion of monoclonal antibody applications in formaldehyde-fixed, paraffin-embedded tissues.
- Utilizing antibodies against proliferation antigens (e.g., Ki-67) and tumor suppressor genes (e.g., p53).
Main Results:
- Increased availability and application of monoclonal antibodies.
- Refined immunohistochemical definitions for small cell lymphoma entities.
- Enhanced evaluation of the biologic potential of lymphomas and leukemias.
Conclusions:
- Immunohistochemistry is a vital tool in modern hematologic malignancy diagnosis.
- Monoclonal antibodies and proliferation markers significantly advance diagnostic accuracy.
- Further research into immunohistochemical markers will refine understanding and treatment of these diseases.